{"id":"W3195241595","doi":"10.1016/s0090-8258(21)00656-9","title":"1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; BRCA mutation; Internal medicine; Oncology; Clinical endpoint; Ovarian cancer; Olaparib; Population; PARP inhibitor; Cisplatin; Chemotherapy; Phases of clinical research; Cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001311684,0.001281899,0.002689607,0.0004817921,0.0003329222,0.0009729744,0.0008649262,0.001322777,0.00498476],"category_scores_gemma":[0.001409181,0.0005406445,0.001738664,0.0005310309,0.0008602016,0.001024217,0.0003170221,0.003502144,0.0007618774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009298163,"about_ca_system_score_gemma":0.0009636396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009510774,"about_ca_topic_score_gemma":0.003161456,"domain_scores_codex":[0.9993995,0.0003504518,0.00002272877,0.00008730942,0.00003665494,0.0001032246],"domain_scores_gemma":[0.9992428,0.00025536,0.0001692927,0.00006578652,0.00003201172,0.0002347843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9221886,0.008910599,0.001726344,0.0005902329,0.001807288,0.00007294359,0.00006369357,0.001156704,0.003821166,0.0001608822,0.001622254,0.05787929],"study_design_scores_gemma":[0.7948933,0.1922741,0.006658073,0.00006606029,0.001344614,0.0001464991,0.00004764501,0.001335643,0.001078036,0.0003260526,0.001793585,0.00003638286],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870536,0.007474986,0.0003855646,0.0007487982,0.000284413,0.0007095577,0.0009447537,0.0001340396,0.002264421],"genre_scores_gemma":[0.9888159,0.003650324,0.0007495162,0.001224044,0.000295187,0.0006896519,0.001378235,0.00003768895,0.003159456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00498476,"threshold_uncertainty_score":0.01667571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01622045015881876,"score_gpt":0.3306101091723185,"score_spread":0.3143896590134998,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}